Human Pharmaceuticals
Eurofins Regulatory Science Services’ environmental risk assessment capabilities for human pharmaceuticals provide the environmental data and guidance you need to meet testing and timing requirements.
Evaluating a pharmaceutical’s potential environmental impact requires expertise in both drug development and environmental testing. At Eurofins, our scientists have both.
Eurofins has a long history of partnering with pharmaceutical companies to support drug development through a deep understanding of global regulatory requirements for environmental submissions. We can guide you through the assessment process with unmatched efficiency, providing all the data you need, exactly when you need it.
Eurofins RSS will help you choose the optimal time to start your study in order to avoid submission delays. With environmental risk assessment studies taking 10 to 12 months or longer, we know you don’t have time to waste. Once your study begins, our program managers and scientific advisors will be there every day to guide you and your project to successful completion.
Eurofins’ industry leadership in chemical registration support is built on the combined expertise of Wildlife International, ABC Laboratories, PTRL West and PTRL Europe, which recently merged under the Eurofins RSS banner. With more than 120 years of combined laboratory experience in studies involving environmental fate, ecotoxicological safety studies, plant and animal metabolism, and product chemistry, our scientists design and execute high-quality experiments to produce high-quality data.
Our pharmaceutical environmental risk assessment capabilities include:
- Document preparation
- Evaluation of testing needs
- Categorical exclusions
- FDA-CVM Environmental Assessments
- FDA-CDER Environmental Assessments
- EMA Environmental Risk Assessments
- Aquatic Safety Studies
- Terrestrial Safety Studies
- Avian Safety Studies
- Plant metabolism
- Environmental fate
- Product chemistry
- Method development/method validation
Contact erssinfo@eurofins.com for more information!